| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 4, 2004
Accepted on March 18, 2004
From the Nephrology and Hypertension Section (E.A.J., R.-X.T.), Veterans Affairs Medical Center, Miami, Fla.; the Research Section (E.G.D.), Veterans Affairs Medical Center, Minneapolis, Minn.; and the Renal Division and Vascular Biology Institute (E.A.J., L.R.), University of Miami, Fla.
* To whom correspondence should be addressed. E-mail: ejaimes{at}med.miami.edu.
Objective--Endothelial dysfunction is an early manifestation of cigarette smoke (CS) toxicity. We have previously demonstrated that CS impairs nitric oxide (NO)-mediated endothelial function via increased generation of superoxide anion. In these studies, we investigated whether stable compounds present in CS activate specific pathways responsible for the increased endothelial superoxide anion production.
Methods and Results--Short exposure of bovine pulmonary artery endothelial cells (BPAECs), human pulmonary artery endothelial cells, and rat pulmonary arteries to CS extracts (CSEs) resulted in a large increase in superoxide anion production (20-fold, 3-fold, and 2-fold increase, respectively; P<0.05 versus control), which was inhibited by the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitors diphenyleneiodinium, apocynin, and gp91 docking sequence-tat peptide but not by oxypurinol, the NO synthase inhibitor NG-nitro-L-arginine methyl ester, or the mitochondrial respiration inhibitor rotenone. Exposure of BPAECs to acrolein, a stable thiol-reactive agent found in CS, increased superoxide anion production 5-fold, which was prevented by prior inhibition of NADPH oxidase.
Conclusions--These studies demonstrate that thiol-reactive stable compounds in CS can activate NADPH oxidase and increase endothelial superoxide anion production, thereby reducing NO bioactivity and resulting in endothelial dysfunction. Clinically, these studies may contribute to the development of agents able to mitigate CS-mediated vascular toxicity.
This article has been cited by other articles:
![]() |
P. Haddad, S. Dussault, J. Groleau, J. Turgeon, S.-E. Michaud, C. Menard, G. Perez, F. Maingrette, and A. Rivard Nox2-Containing NADPH Oxidase Deficiency Confers Protection From Hindlimb Ischemia in Conditions of Increased Oxidative Stress Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1522 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Csiszar, N. Labinskyy, A. Podlutsky, P. M. Kaminski, M. S. Wolin, C. Zhang, P. Mukhopadhyay, P. Pacher, F. Hu, R. de Cabo, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2721 - H2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yao, I. Edirisinghe, S.-R. Yang, S. Rajendrasozhan, A. Kode, S. Caito, D. Adenuga, and I. Rahman Genetic Ablation of NADPH Oxidase Enhances Susceptibility to Cigarette Smoke-Induced Lung Inflammation and Emphysema in Mice Am. J. Pathol., May 1, 2008; 172(5): 1222 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Barbieri, L. Ruggiero, E. Tremoli, and B. B. Weksler Suppressing PTEN Activity by Tobacco Smoke Plus Interleukin-1{beta} Modulates Dissociation of VE-Cadherin/{beta}-Catenin Complexes in Endothelium Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tang, J. Lu, J. P. Walterscheid, H.-H. Chen, D. A. Engler, T. Sawamura, P.-Y. Chang, H. J. Safi, C.-Y. Yang, and C.-H. Chen Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1 J. Lipid Res., January 1, 2008; 49(1): 33 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Orosz, A. Csiszar, N. Labinskyy, K. Smith, P. M. Kaminski, P. Ferdinandy, M. S. Wolin, A. Rivera, and Z. Ungvari Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H130 - H139. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Jaimes, R.-X. Tian, and L. Raij Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H76 - H82. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Stokes NAD(P)H oxidase: where there's smoke, there's fire Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H119 - H120. [Full Text] [PDF] |
||||
![]() |
T. S. Perlstein and R. T. Lee Smoking, Metalloproteinases, and Vascular Disease Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 250 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Barnoya and S. A. Glantz Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking Circulation, May 24, 2005; 111(20): 2684 - 2698. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |